AidaCVegaMD

Vice Chair Ambulatory Care Mount Sinai Health Director, Primary Care Associates Mount Sinai Medical Center

Dr. Vega is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
234 E 85th St
New York, NY 10028
Phone+1 212-241-6585

Fax+1 212-731-3391

University of ConnecticutResidency, Internal Medicine, 1981 - 1983
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1980 - 1981
Boston University School of MedicineClass of 1980

Top Doctors: New York Metro Area Castle Connolly, 2013-2014
New York Magazine: Top Doctors Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2014
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2014
Top Doctors: Florida Castle Connolly, 2000
Join now to see all

PubMed

159 citations
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff
Jennifer McNeely, Pritika C. Kumar, Traci Rieckmann, Erica Sedlander, Sarah Farkas
Addiction Science & Clinical Practice. 2018-04-09
31 citations
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.
Jennifer McNeely, Angéline Adam, John Rotrosen, Sarah E. Wakeman, Timothy E. Wilens
JAMA Network Open. 2021-05-03
2 citations
Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program.
Aniwaa Owusu Obeng, Stuart A Scott, Tom Kaszemacher, Stephen B Ellis, Ana Mejia
Clinical Pharmacology and Therapeutics. 2023-02-01

1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease PatientsJune 20th, 2022
The Mount Sinai Medical Center Received a High Safety Rating in TheJuly 28th, 2018